Drug & intervention

hydrocortisone

RxCUI 5492

Clinical trials21
Recruiting3
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Cortisol

Cortisol is a steroid hormone in the glucocorticoid class of hormones and a stress hormone. When used as medication, it is known as hydrocortisone. Cortisol is produced in many animals, mainly by the zona fasciculata of the adrenal cortex in an adrenal gland. In other tissues, it is produced in lower quantities. By a diurnal cycle, cortisol is released and increases in response to stress and a low blood-glucose concentration. It functions to increase blood sugar through gluconeogenesis, suppress the immune system, and aid in energy metabolism. It also decreases bone formation. These stated functions are carried out by cortisol binding to glucocorticoid or mineralocorticoid receptors inside a cell, which then bind to DNA to affect gene expression.

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

21 shown
Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)NCT06892210 · 2026-03-10
RECRUITING
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)NCT06136624 · 2023-12-31
RECRUITING
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650 · 2023-12-18
RECRUITING
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)NCT06136598 · 2024-01-30
COMPLETED
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)NCT06104449 · 2023-11-14
COMPLETED
Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen OverproductionNCT01422733 · 2018-06-01
WITHDRAWN
Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen ExcessNCT01422707 · 2018-01-19
WITHDRAWN
Effects of Glucocorticoids on Cognition in HIV-infected WomenNCT03237689 · 2017-11-20
COMPLETED
Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect HungerNCT02722200 · 2016-05-01
COMPLETED
Endoscopic Treatment of Salivary Glands Affected by Sjögren's SyndromeNCT02112019 · 2014-06-01
UNKNOWN
A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe AsthmaticsNCT02270827 · 2014-06-01
TERMINATED
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone AdministrationNCT01710202 · 2012-10-01
COMPLETED
Ketoconazole and Dexamethasone in Prostate CancerNCT01036594 · 2009-12-11
COMPLETED
Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate CancerNCT00953576 · 2009-09-29
TERMINATED
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate CancerNCT00859781 · 2009-06-01
ACTIVE_NOT_RECRUITING
Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior ChemotherapyNCT00895310 · 2009-05-01
COMPLETED
Adrenal Insufficiency in Cirrhotics With Ascites. Effects of Hydrocortisone on Renal and Haemodynamic FunctionNCT00657306 · 2008-05-01
UNKNOWN
Trilostane for Androgen-Independent Prostate CancerNCT00181597 · 2004-03-01
COMPLETED
Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?NCT00186264 · 2002-08-01
COMPLETED
The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight RegulationNCT00688987 · 2000-08-01
COMPLETED
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsNCT05974410
AVAILABLE

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.